Amit Sachdev sold $27.5M of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Feb 19, disclosed Feb 23, 4 days later.

Value, as filed

$27.5M

58,613 sh across 8 lots

Executed

Feb 19

the trade date, as filed

Disclosed

Feb 23

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AS Amit Sachdev EVP Chief Patient & Ext Af Off profile →

Amit Sachdev (EVP Chief Patient & Ext Af Off) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $27.5M of VRTX (58,613 sh across 8 lots, as filed), executed Feb 19.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 90 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Amit Sachdev in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $898K
1,846 sh × $486.35
Exec Feb 25
Filed Feb 26 · 5:30 PM ET